| Name | Title | Contact Details |
|---|---|---|
Pete McCabe |
Chief Executive Officer | Profile |
Samantha Segall |
Vice President, Head of External Affairs | Profile |
Susan Lawlor |
Deputy General Counsel | Profile |
Aden Fine |
General Counsel and Chief Privacy Officer | Profile |
ImClone Systems is one of the leading companies in the Healthcare, Pharmaceuticals, & Biotech sector.
Eidos Therapeutics, a subsidiary of BridgeBio Pharma, is developing AG10 as a targeted therapeutic for transthyretin amyloidosis.
NFlection is a biopharmaceutical company focused on the development of novel therapies to address the needs of patients with neurofibromatosis type 1, immunosuppressant-mediated squamous cell carcinoma, and congenital birthmarks such as keratinocytic epidermal nevi and nevus sebaceous.
THEON is a patient-focused drug discovery company developing small molecule correctors of RNA pathobiology.
Highmark Delaware is a Wilmington, DE-based company in the Healthcare, Pharmaceuticals, and Biotech sector.